AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Endoglim Trio 2.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Arkas Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Endoglim Trio 2.2mg Tablet SR

Tridin-G 2.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, facilitating improved blood glucose control. Administer Tridin-G 2.2mg Extended-Release Tablets with food, consistently at the same time daily for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with well-managed blood sugar. Discontinuation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Learn to identify and manage these symptoms. Maintain consistent meal timing and carry a readily available fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Endoglim Trio 2.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Endoglim Trio 2.2mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Endoglim Trio 2.2mg Tablet SR on an empty stomach.

Common Side effects of Endoglim Trio 2.2mg Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Endoglim Trio 2.2mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Endoglim Trio 2.2mg Tablet SR on an empty stomach.

How Endoglim Trio 2.2mg Tablet SR works:

Endoglim Trio SR tablets (2.2mg) contain a triple-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Endoglim Trio 2.2mg Tablet SR is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Endoglim Trio 2.2mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any hazards before recommending its use. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Endoglim Trio 2.2mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

The use of Endoglim Trio 2.2mg SR tablets is likely inadvisable for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.

LiverLiverCAUTION

Exercise caution when prescribing Endoglim Trio 2.2mg SR tablets to patients with liver impairment; dosage modification may be necessary. Consult a physician. For individuals with mild to moderate hepatic dysfunction, initiate treatment with a reduced Endoglim Trio 2.2mg SR tablet dosage; however, its use is contraindicated in those with severe liver disease.

What if you forget to take Endoglim Trio 2.2mg Tablet SR :

Should you forget a dose of Endoglim Trio 2.2mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Endoglim Trio 2.2mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Diabetes medication

FAQs on Endoglim Trio 2.2mg Tablet SR

Endoglim Trio 2.2mg Extended-Release Tablets contain glimepiride, metformin, and voglibose. This triple-drug therapy manages type 2 diabetes mellitus in adults. Effective blood sugar control requires its use alongside a healthy diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and enhances insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, specifically reduces post-meal blood sugar spikes. This formulation is unsuitable for type 1 diabetes.
Taking Endoglim Trio 2.2mg Sustained-Release Tablets may cause frequent side effects including low blood sugar, queasiness, loose stools, taste changes, gas, abdominal discomfort, head pain, skin eruptions, and upper respiratory infections.
Patients with hypersensitivity to Endoglim Trio 2.2mg Tablet SR constituents or inactive ingredients should not use this medication. Its use is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disease, colonic ulcers, and metabolic acidosis, including diabetic ketoacidosis.
Combining Endoglim Trio 2.2mg SR tablets and alcohol is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and elevates the probability of lactic acidosis.
Indeed, Endoglim Trio 2.2mg Tablet SR can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar include nausea, headache, irritability, increased hunger, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This adverse effect is more probable if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medications are used. Consequently, consistent blood glucose monitoring is crucial. It's advisable to carry glucose tablets, honey, or fruit juice at all times.
Maintain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Endoglim Trio 2.2mg Table...
155
MRP 189
17% off